Webinar | IVDD to IVDR: Mind the Gap Before You Apply
DNV and MedEnvoy present a one-hour webinar on 9 December 2026 on the IVDD to IVDR transition for Class B and Class A sterile IVD manufacturers preparing for the 2027 milestones.
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 1–9 of 1001
DNV and MedEnvoy present a one-hour webinar on 9 December 2026 on the IVDD to IVDR transition for Class B and Class A sterile IVD manufacturers preparing for the 2027 milestones.
FDA fees for medical device registration depend on classification. The FY 2027 annual establishment registration fee is $13,785, plus pathway fees for 510(k), De Novo, and PMA submissions.
AI was among the most discussed topics at RAPS Convergence 2026. Rocio Fallas shares her impression of where regulators and industry agree, and what manufacturers should prepare for in 2027.
A valid CE certificate and a clean audit history do not guarantee that a shipment clears the border. Daryl Wisdahl and Brittany Dunning explain what does.
On 21 October 2026, the UK government confirmed it intends to indefinitely recognize CE marked devices certified under the EU MDR and IVDR in Great Britain. GB obligations remain.
Swissmedic made the importer linking function available in swissdamed on 1 October 2026. Swiss importers must now link their…
Most Class III devices need Premarket Approval, the FDA's most demanding pathway. Here is what the PMA process involves, from trials and application contents to review stages and common mistakes.
Health Canada has revised its medical device shortage guidance. New reporting windows, advance notice requirements and a broader discontinuation rule apply from 17 June 2027.
The U.S. Food and Drug Administration (FDA) has published a final order expanding 510(k) exemptions for…
Showing 1–9 of 1001